Combination therapeutic effects of high intensity focused ultrasound and Metformin for the treatment of adenomyosis
Combined high intensity focused ultrasound (HIFU) and metformin treatment significantly reduced menstrual flow and pain with lower inflammatory cytokine levels compared to single HIFU treatment in adenomyosis patients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study evaluated combined therapy with high intensity focused ultrasound (HIFU) plus metformin versus single HIFU in 274 patients with adenomyosis admitted to Jinan Maternity and Child Care Hospital. The authors report that both menstrual flow and pain were significantly reduced in the combined-treatment group compared with single HIFU (P<0.01), and that inflammatory cytokine levels decreased relative to baseline (P<0.01). The main limitation explicitly implied by the presentation is the lack of detailed methods or controls in the provided text, including how cytokines were measured and the extent of baseline comparability. This paper is centrally about endometriosis and/or adenomyosis — specifically adenomyosis — assessing whether adding metformin to HIFU improves symptom and inflammatory cytokine outcomes.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
3,706 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- Adénocarcinome endométrioïde résultant de foyers d’adénomyose via openalex
- Adenomyosis: Review of the Literature via openalex
- Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy via openalex
- Clinical Predictors of Long-term Success in Ultrasound-guided High-intensity Focused Ultrasound Ablation Treatment for Adenomyosis via openalex
- Current status of high-intensity focused ultrasound for the management of uterine adenomyosis via openalex
- Effective ablation therapy of adenomyosis with ultrasound‐guided high‐intensity focused ultrasound via openalex
- Évolutions physiopathologiques, diagnostiques et thérapeutiques dans la prise en charge de l’adénomyose : revue de la littérature via openalex
- Feasibility of laparoscopic high-intensity focused ultrasound treatment for patients with uterine localized adenomyosis via openalex
- Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis via openalex
- High-intensity focused ultrasound ablation of uterine localized adenomyosis via openalex
- High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results via openalex
- Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis via openalex
- Safety and Efficacy of High Intensity Focused Ultrasound Ablation Therapy for Adenomyosis via openalex
- Safety of ultrasound-guided high-intensity focused ultrasound ablation for diffuse adenomyosis: A retrospective cohort study via openalex
- Transvaginal ultrasound for diagnosis of adenomyosis: a review via openalex
- Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center via openalex
- Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid & adenomyosis: A single center experience from the Republic of Korea via openalex
- W2212461507 via openalex
- W2107983983 via openalex
- W2040972158 via openalex
Cited by (13)
- Female Sexual Dysfunction After High-Intensity Focused Ultrasound versus Laparoscopic Total Hysterectomy for Adenomyosis: Associations with Anxiety and Depression 2026
- Analysis of HIFU Therapy for Adenomyosis: A Systematic Review 2025
- Experimental Models of Adenomyosis as the Basis for Developing New Methods in the Treatment of the Disease. Part II. Evaluation of the Effectiveness of Adenomyosis Treatment in Female Wistar Rats 2025
- Current Trends and Future Strategies on Diagnosis and Management of Adenomyosis: An Updated Review 2024
- Adenomyosis: Current knowledge, Recent Advances and Future Perspective 2023
- Hemoperitoneum caused by bleeding of adenomyosis: a case report 2021
- Surgical strategies in uterine adenomyosis 2021
- Adjuvant Therapy of HIFU Ablation for Adenomyosis 2021
- Management of uterine adenomyosis: current trends and uterine artery embolization as a potential alternative to hysterectomy 2019
- High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up 2019
- Endometriosis treatment with shock waves: A novel approach 2019
- Influences of screening magnetic resonance imaging parameters on high-intensity focused ultrasound outcome for adenomyosis 2018
- Current status of high-intensity focused ultrasound for the management of uterine adenomyosis 2016
Source provenance
- europepmc
- last seen: 2026-08-07T06:07:27.085738+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:01.354358+00:00